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Abstract
Background: Guanylic nucleotides are both macromolecules constituents and crucial regulators
for a variety of cellular processes. Therefore, their intracellular concentration must be strictly
controlled. Consistently both yeast and mammalian cells tightly correlate the transcription of genes
encoding enzymes critical for guanylic nucleotides biosynthesis with the proliferation state of the
cell population.
Results:  To gain insight into the molecular relationships connecting intracellular guanylic
nucleotide levels and cellular proliferation, we have studied the consequences of guanylic
nucleotide limitation on Saccharomyces cerevisiae cell cycle progression. We first utilized
mycophenolic acid, an immunosuppressive drug that specifically inhibits inosine monophosphate
dehydrogenase, the enzyme catalyzing the first committed step in de novo GMP biosynthesis. To
approach this system physiologically, we next developed yeast mutants for which the intracellular
guanylic nucleotide pools can be modulated through changes of growth conditions. In both the
pharmacological and genetic approaches, we found that guanylic nucleotide limitation generated a
mother-daughter separation defect, characterized by cells with two unseparated daughters. We
then showed that this separation defect resulted from cell wall perturbations but not from impaired
cytokinesis. Importantly, cells with similar separation defects were found in a wild type untreated
yeast population entering quiescence upon nutrient limitation.
Conclusion: Our results demonstrate that guanylic nucleotide limitation slows budding yeast cell
cycle progression, with a severe pause in telophase. At the cellular level, guanylic nucleotide
limitation causes the emergence of cells with two unseparated daughters. By fluorescence and
electron microscopy, we demonstrate that this phenotype arises from defects in cell wall partition
between mother and daughter cells. Because cells with two unseparated daughters are also
observed in a wild type population entering quiescence, our results reinforce the hypothesis that
guanylic nucleotide intracellular pools contribute to a signal regulating both cell proliferation and
entry into quiescence.
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Background
Guanylic nucleotides are critical for multiple crucial cellu-
lar processes such as replication, transcription, translation
and signalization via small GTPases. Most cell types recy-
cle GMP from guanosine or guanine, which are either
taken up from the surrounding environment or synthe-
sized by the intracellular metabolism. GMP can also be
synthesized de novo from IMP via two consecutive enzy-
matic steps, both highly conserved through evolution. Ini-
tially, the inosine monophosphate dehydrogenase
(IMPDH) catalyzes conversion of IMP into XMP, the first
committed step in de novo GMP biosynthesis. Subse-
quently, GMP synthetase converts the newly produced
XMP into GMP.
The expression of IMPDH encoding genes is tightly regu-
lated. In both yeast and mammalian cells, high guanylic
nucleotide levels repress the transcription of IMPDH
encoding genes [1,2]. More strikingly, the transcription of
IMPDH encoding genes in mammals is linked to cellular
proliferation. In non-dividing cells, the expression level of
IMPDHs is low, whereas it is highly increased in actively
proliferating cells such as cancerous cells [3-6]. Further,
IMPDH over-expression bypasses the anti-proliferative
effect of p53, indicating that this p53 function requires
proper control of IMPDH activity [7].
Saccharomyces cerevisiae cells have two major sources of
guanylic nucleotides: intracellular IMP and extracellular
guanine. Therefore GMP synthesis fully relies on IMPDH
and GMP synthetase activities in the absence of guanine in
the growth medium. Consistently, mutations in these cog-
nate genes lead to guanine auxotrophy [8,9]. Similar to
mammalian cells, S. cerevisiae genes involved in GMP bio-
synthesis are highly expressed during exponential growth,
but are actively repressed through specific regulatory
sequences when cells arrest proliferation upon nutrient
limitation [10]. Moreover, the intracellular GTP/GDP
ratio drastically decreases when yeast cells enter a quies-
cent state [11]. These experiments lead to the appealing
hypothesis that intracellular guanylic nucleotides levels
contribute to a signal regulating cell proliferation. How-
ever, the molecular pathways linking cell cycle progres-
sion to IMPDH activity, and thus to intracellular guanylic
nucleotide pools remain unknown.
Mycophenolic acid (MPA) is a well-characterized non-
competitive and reversible inhibitor of IMPDH that
severely depletes intracellular GTP pool down to 10% of
normal level [12,13]. MPA reduces or even abrogates pro-
liferation of various cell types [14,15]. MPA particularly
affects lymphocyte division and because it has few sec-
ondary effects, its pro-drug form, the mycophenolate
mofetil (Cellcept, Roche), is in path to replace
cyclosporine A as a commonly used immunosuppressive
drug. At the cellular level, MPA inhibits lymphocyte cell
cycle progression by arresting cells in G1. Although this
effect correlates with the depletion of guanylic nucleotide
pools [13,16], addition of guanosine and 8-aminoguano-
sine, which can partially replenish guanylic nucleotide
pools, does not allow MPA treated cells to re-enter G2/M
[17]. Thus, MPA treatment, although apparently blocking
cells in G1, could also affect later steps of the cell cycle. In
budding yeast, MPA treatment slows cell proliferation and
causes various effects on gene expression and thus on the
yeast proteome [18]. In a previous study, we have shown
that MPA affects yeast cell size, DNA content, budding
pattern and causes occasional perturbations of actin and
microtubule cytoskeletons [18]. In addition, several
mutants affected for various cellular functions are hyper-
sensitive to MPA [19]. However, these data do not point
at an obvious molecular process that would account for
the effects of MPA on cell proliferation.
Here, to gain insight into the molecular relationships
between intracellular guanylic nucleotide levels and cell
cycle progression, we studied the effects of MPA treatment
on Saccharomyces cerevisiae cell cycle progression. We first
demonstrated that, although cells did not arrest in a par-
ticular cell cycle stage (confirming that there was no
checkpoint for guanylic nucleotides in yeast), a large pro-
portion of the population was slowed in telophase. We
further observed that many MPA treated cells presented
two unseparated daughter cells. We have shown that this
specific morphology was due to a defect in mother-daugh-
ter separation and that it was probably a consequence of
cell wall perturbations. To validate the results obtained
with MPA, we developed yeast mutants in which guanylic
nucleotide pools could be modulated by the composition
of the growth medium. Using these genetic tools, we con-
firmed that cell separation was indeed the cell cycle step
mostly perturbed by guanylic nucleotides starvation.
Finally, the observation that cells entering quiescence also
displayed the characteristic "two-daughter cells" mor-
phology strongly suggests that a decrease in intracellular
guanylic nucleotide levels may be part of a signal for yeast
cells to enter stationary phase.
Results
Mycophenolic acid treatment particularly affects the last 
step of the yeast cell cycle
MPA treatment affects yeast growth in a concentration-
dependent manner [18]. This growth defect can result
from either a general slowing down of the entire cell cycle
or a pause in a specific cell cycle step. To gain insight into
this issue, wild type yeast cells were synchronized in G1
using alpha factor and released in either the absence or the
presence of 100 µg/mL of MPA. At such a concentration,
MPA does not affect cell viability nor totally arrest cell
growth [18]. Higher MPA concentration gave similarBMC Cell Biology 2005, 6:24 http://www.biomedcentral.com/1471-2121/6/24
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effects, most probably because yeast cells detoxified the
drug [19]. We then monitored cell cycle progression by
FACS. As shown in figure 2A, although progression
through initial cell cycle steps was slower for MPA treated
cells, the population lagged most predominantly in a 2N
DNA content stage. Fluorescence microscopy revealed
that although for MPA-treated cells the anaphase onset
was slightly delayed, its duration was almost similar to the
anaphase of control cells (Fig. 2B). In fact, treated cells
were mostly pausing in a stage where the DNA masses
were totally separated (telophase, Fig. 2C). To our sur-
prise, in the treated population we observed mother cells
with two apparent daughter cells (Fig. 2D and 2E). The
cells with two apparent daughters represented more than
50% of the population 300 minutes after the release from
G1. To confirm this result, a non-synchronized popula-
tion was treated with MPA. After 4 hours in the presence
of MPA, more than 30% of the budding cells displayed
two apparent daughters (Fig. 3), a phenotype we refer to
as "bibudded", for simplicity.
A "bibudded" phenotype could result either from a single
mother cell with two daughter cells, or from an unrelated
G1 cell "sticking" to a normally budding cell. Since MPA
treated cells were found to be sensitive to sonication, we
used a fluorescence-based approach to distinguish
between these two possibilities. Equal amounts of cells
over-expressing a green variant of GFP were mixed with
cells over-expressing a blue variant of GFP, grown to
OD600 nm 0.2 and then treated with MPA.
After 4 hours of incubation, less than 1% (0.3% ± 0.3,
N>100 for each of 4 independent experiments) of "bibud-
ded" cells displayed one apparent daughter expressing a
different GFP variant than its joined budding cell. Thus,
more than 99% of the cells with two apparent daughters
were monocolor, which is far more than the 50% expected
for a random population of false "bibudded" cells. This
experiment demonstrated that the population is indeed
composed of a large proportion of cells with two attached
daughters. In conclusion, MPA treatment particularly
slowed down telophase and caused the appearance of
cells with two unseparated daughters.
MPA effects are reversed by extracellular guanine and are 
not a consequence of translation inhibition
To generate guanylic nucleotides, the requirement for
IMPDH activity can be bypassed by the addition of gua-
nine into the growth medium (Fig. 1). To show that the
effects of MPA on cell cycle progression specifically result
from a decrease of intracellular guanylic nucleotide pools,
we treated cells with MPA in guanine-supplemented
growth medium. In these conditions, only 3% of the cells
displayed two unseparated daughters (Fig. 3) and no
growth defect was detected (data not shown and [18]).
As 100 µg/mL MPA causes a significant decrease of the
translation efficiency [18], we considered the possibility
that "bibudded" cells result from impaired translation. To
this end, we examined cells treated for 4 hours with the
general translational inhibitor cycloheximide at a concen-
tration that abolished translation [20]. In contrast to
MPA-treated cells, cycloheximide-treated cells did not
exhibit more than one bud (0.8% ± 0.3% of the budding
cells had two buds, N>200). Therefore, by decreasing
intracellular guanylic nucleotide pools, MPA treatment
Schematic representation of the purine nucleotide synthesis  pathway in yeast Figure 1
Schematic representation of the purine nucleotide 
synthesis pathway in yeast. The solid thin lines represent 
the plasma membrane. ADP: adenosine-5'-diphosphate; AMP: 
adenosine-5'-monophosphate; ATP: adenosine-5'-triphos-
phate; GDP: guanosine-5'-diphosphate; GMP: guanosine-5'-
monophosphate; GTP: guanosine-5'-triphosphate; IMP: inos-
ine-5'-monophosphate; PRPP: 5-phosphoribosyl-1-pyrophos-
phate; SAMP: S-adenosine-5'-monophosphate; XMP: 
xanthosine-5'-monophosphate. Genes are shown in grey 
italic font and encode the following enzymatic activities: 
AAH1: adenine deaminase; ADE8: 5'-phosphoribosylglycina-
mide formyltransferase; ADE12: adenylosuccinate synthetase; 
ADE13: adenylosuccinate lyase; ADK1: AMP kinase; AMD1: 
AMP deaminase; APT1: adenine phosphoribosyltransferase; 
FCY2: purine cytosine permease; GUA1: GMP synthetase; 
GUK1: GMP kinase; HPT1: hypoxanthine-guanine phosphori-
bosyltransferase; IMD2, IMD3, and IMD4: IMP dehydroge-
nases (IMD1 is not indicated here because it is not expressed 
and is thought to be a pseudogene). Mycophenolic acid 
(MPA) inhibits IMP dehydrogenases.
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Effects of MPA on the yeast cell cycle progression Figure 2
Effects of MPA on the yeast cell cycle progression. A. Cell cycle progression of a yeast cell population synchronized in 
G1 with alpha factor and released in the absence (left) or in the presence of 100 µg/mL MPA (right) analyzed by FACS. B. Per-
centage of cells in anaphase in function of the progression through the cell cycle. Cells are the same as in A. More than 200 
cells were counted for each time point. Cells were scored as being in anaphase when the mother cell DNA mass was clearly 
still connected to the DNA mass of the daughter cell, typically as the third cell shown in the – MPA panel of figure 2E. C. Per-
centage of cells in telophase in function of the progression through the cell cycle. Cells are the same as in A. More than 200 
cells were counted for each time point. Cells were scored as being in telophase when displaying two clearly separated DNA 
masses, typically as the fourth cell shown in the – MPA panel of figure 2E. D. Percentage of cells with two or more daughter 
cells in function of the progression through the cell cycle. Cells are the same as in A. More than 200 cells were counted for 
each time point. E. Cells representative of each cell cycle stage (phase contrast and propidium iodide staining of the nucleus) 
for the untreated (top panel) or MPA treated (bottom panel) population. The unusual elongated cell morphology is due to the 
alpha factor treatment. Arrows indicate examples of second daughter cell appearing while the first daughter cell is not yet sep-
arated from the mother cell. Bar: 2 µm.
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caused a slowing down of the yeast cell cycle progression,
the telophase being mostly affected. Consequently,
"bibudded" cells accumulate and this, independently of
MPA effects on translation efficiency.
Mutations affecting the guanylic nucleotide biosynthesis 
cause the emergence of cells with two unseparated 
daughters
Although addition of guanine to the growth medium fully
reversed the effects of MPA, pharmacological studies have
the caveat of possible secondary targets. Thus, we devel-
oped mutant yeast strains in which the guanylic nucle-
otide pools can be modulated by a simple change of the
growth conditions. Because of genetic redundancy in
IMPDH encoding genes, no single imd mutant is auxo-
troph for guanine, we therefore chose to use a mutant in
the  GUA1  gene which encodes GMP synthetase, the
enzyme converting XMP into GMP (Fig. 1). A gua1∆
mutant is unable to synthesize guanylic nucleotides in the
absence of guanine in the growth medium. To compare
the effects of guanylic nucleotide starvation with the
depletion of another purine, we combined the gua1∆  dele-
tion with the ade8∆  deletion that leads to adenine auxo-
trophy. The double mutant ade8∆  gua1∆  is thus auxotroph
for both guanine and adenine (Fig. 4A). When both gua-
nine and adenine were provided in the growth medium,
the double mutant ade8∆  gua1∆  grew like the isogenic
ade8∆  control strain and, the ade8∆   gua1∆  population
contained less than 3% of "bibudded" cells (Fig. 4A and
4B). After a 4-hour shift to a growth medium lacking gua-
nine, 20% of the cells displayed two unseparated daughter
cells. By contrast, shifting the cells to growth medium
lacking adenine did not induce the emergence of "bibud-
ded" cells (Fig. 4B). Therefore, "bibudded" cells appear-
ance is specific to a guanylic nucleotide starvation.
In order to diminish the intracellular guanylic nucleotide
pools by another route, we constructed an aah1∆  amd1∆
double mutant. The AAH1 gene encodes adenine amino-
hydrolase, an enzyme converting adenine into hypoxan-
thine. The AMD1  gene encodes the AMP deaminase
enzyme, which converts AMP into IMP (Fig. 1). The de
Effects of MPA treatment on an unsynchronized yeast cell population Figure 3
Effects of MPA treatment on an unsynchronized yeast cell population. Percentage of budding cells with two daughter 
cells after 4 hours growth in SD medium without (left) or with guanine (right) in the absence (grey bars) or in the presence 
(white bars) of 100 µg/mL MPA. More than 200 cells were counted for each condition.
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Effects of guanylic nucleotide starvation using mutants of the purine nucleotide biosynthesis pathway Figure 4
Effects of guanylic nucleotide starvation using mutants of the purine nucleotide biosynthesis pathway. A. 
Growth of an ade8∆  gua1∆  double mutant and an isogenic ade8∆  single mutant on SD medium containing the indicated 
purines. The SD + ADE + GUA medium contains 25% Adenine / 75% Guanine ratio (total purine concentration of 0.3 mM). B. 
The ade8∆  gua1∆  strains was grown in SD medium containing 25% Adenine / 75% Guanine ratio to OD600 nm = 0.2; then shifted 
into the indicated medium. After 4 hours of incubation at 30°C, the percentage of cells with two daughters among budding 
cells was counted. More than 200 cells were counted for each condition. C. Growth of the WT strain, isogenic single amd1∆  
or aah1∆  mutant strains and amd1∆  aah1∆  double mutant strain on SD medium, SD medium supplemented with adenine or 
SD medium supplemented with hypoxanthine. D. WT strain (left) and amd1∆  aah1∆  double mutant strain (right) were grown 
in SD medium to OD600 nm = 0.2 and then shifted into the indicated medium. After 4 hours of incubation at 30°C, the percent-
age of cells with two daughters among budding cells was counted. More than 200 cells were counted for each condition.
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novo synthesis of IMP from PRPP is inhibited by the pres-
ence of adenine in the growth medium [21]. Conse-
quently, in the presence of adenine, the aah1∆   amd1∆
double mutant has theoretically no path to synthesize
GMP, neither from the de novo pathway nor from adenine.
Accordingly, without extracellular guanine (or hypoxan-
thine), the guanylic nucleotide pools of the aah1∆  amd1∆
double mutant cannot be replenished and its growth is
strongly affected (Fig. 4C). The aah1∆   amd1∆  double
mutant was grown in SD medium without purine to
OD600 nm = 0.2 and then shifted into a medium containing
adenine as a sole source of purine. After 4 hours, the per-
centage of cells with two unseparated buds was counted.
As shown in figure 4D, "bibudded" cells only arose when
the aah1∆  amd1∆  double mutant cells were grown in a
medium containing adenine. Thus, modifying the guan-
ylic nucleotide pools through mutations in the purine
nucleotide biosynthesis pathway provoked the same
effect that MPA treatment on the yeast cell cycle: drasti-
cally impaired cell separation without cell cycle arrest,
resulting in cells with two unseparated daughters.
Guanylic nucleotide starvation does not affect the 
formation of cellular structures required for completion of 
cytokinesis
The decrease of intracellular guanylic nucleotide pools
caused the appearance of cells with two unseparated buds.
We further characterized these abnormal cells to identify
the cellular process(es) critically impaired by this starva-
tion and thus likely responsible for this particular
phenotype.
When synchronized cells were treated with MPA, the tim-
ing of emergence and the size of the second bud com-
pared to the first one (see Fig. 2E) strongly suggested that
MPA treated cells started a new cell cycle before the sepa-
ration of the first daughter cell. Cells with two daughters
follow a normal budding pattern (Fig. 2E and 5A), and are
morphologically very different from the multibudded
cells observed for polarity mutants impaired in bud emer-
gence. Thus, the decrease of intracellular guanylic nucle-
otide pools did not likely affect cell polarity
establishment. Further, most of the cells with two buds
presented wild type, polarized actin patches and cables
(Fig. 5A, middle lane), confirming previous studies show-
ing that MPA treatment does not drastically affect the
actin cytoskeleton [18]. In addition, nuclei of the "bibud-
ded" cells are properly positioned (Fig. 5A, bottom lane)
although abnormal mitosis occurs in less than 5% of the
cells (Fig. 5A, + MPA right panel). Thus, polarization
establishment and nuclear segregation were not drasti-
cally affected in cells with two unseparated daughters.
Microscopic observation of synchronized MPA-treated
cells revealed that although anaphase on-set was delayed,
its duration was almost similar to the anaphase in control
cells (Fig. 2B). Therefore, MPA treatment did not critically
affect the mitotic exit network (MEN). Further, MPA treat-
ment did not disrupt proper localization of Tem1p, a RAS
GTPase governing the MEN, neither the localization of its
GTP exchange factor (GEF) Lte1p (Fig. 5B, left and middle
panels). Taken together, these results suggest that MPA
treatment does not significantly perturb anaphase pro-
gression, and consequently does not activate the anaphase
checkpoint.
Because MPA severely affected progression through telo-
phase, we examined the formation of cellular structures
essential for the completion of cytokinesis. Figure 5A
shows that both the first and the second daughter cell can
build an actin cytokinetic ring. Further, more than 95% of
the MPA treated cells (N>200) maintain proper localiza-
tion of the septin Cdc12p (Fig. 5B, right panel), suggesting
strongly that MPA-induced guanylic nucleotide pools
depletion does not affect the septin ring formation and
stability. Moreover, in "bibudded" cells, the septin ring
can split to allow acto-myosin ring contraction for both
the first and the second daughter cell (Fig. 5B, right
panel). Therefore, guanylic nucleotide starved cells dis-
played all the structures required for cytokinesis comple-
tion, and the cellular processes leading to the mother-
daughter separation defect must occur later in the cell
cycle.
Guanylic nucleotide starvation affects cell wall separation
As cells with two unseparated daughters properly form
both actin and septin rings, we examined whether the
cytoplasm was still continuous between the first bud and
its mother. After a 4 hour MPA treatment, we digested the
cell wall with zymolyase and counted the number of
remaining "bibudded" cells. Figure 6A shows that mild
treatment with zymolyase cause a decrease of the "bibud-
ded" cell number suggesting strongly that in those cells,
the cytoplasm is no more continuous between the mother
cell and at least one daughter cell. Thus, guanylic nucle-
otide depletion apparently did not affect cytoplasm con-
striction but rather a later step in the daughter cell
separation process. To confirm this result, we observed
MPA-treated cells by electron microscopy after Thiéry col-
oration, which reveals polysaccharides and therefore the
cell wall. As shown in figure 6B, the cytoplasm between
the mother and the first daughter cell is no longer contin-
uous. Thus, guanylic nucleotide starvation did not affect
cytoplasm closure but a later step in the daughter cell sep-
aration process. Further, the secondary septum of the first
daughter cell appears normal by electron microscopy,
although some small lacunae were occasionally observed
(see inset of Fig. 6B). Therefore, we speculate that
reduction of intracellular guanylic nucleotide pools byBMC Cell Biology 2005, 6:24 http://www.biomedcentral.com/1471-2121/6/24
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Localization of several cellular structures or fusion proteins in cells with two daughters Figure 5
Localization of several cellular structures or fusion proteins in cells with two daughters. A. Cells were untreated 
(right panel) or treated (left panel) with 100 µg/mL MPA for 4 hours. DIC (top lane), actin Alexa-phalloidin staining (middle 
lane) and DAPI staining (bottom lane) are shown. B. Localization of endogenous Tem1p-GFP (left panel), endogenous Lte1p-
GFP (middle panel) and GFP-Cdc12p expressed from a centromeric plasmid under the control of its own promoter (right 
panel) in cells untreated (right of each panel) or treated for 4 hours with 100 µg/mL MPA (left of each panel). Only cells dis-
playing two buds are shown in the case of MPA treatment. Bar: 2 µm.
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MPA treatment particularly impinges on the separation of
the daughter cell by affecting the cell wall digestion.
A large proportion of cells entering quiescence exhibit two 
daughters
In the course of our study, we noticed that a small but
reproducible amount of untreated wild type cells dis-
played two unseparated buds (see for example Fig. 3), a
morphology identical to MPA-treated "bibudded" cells.
We then examined the frequency of "bibudded" cells dur-
ing the growth of a wild type yeast population. To our sur-
prise, whereas less than 2% of the cells with two
unseparated buds could be observed during exponential
phase, when yeast approached the diauxic shift, more
than 30% of the budding population presented two
apparent daughter cells (Fig. 7). This observation
suggested a slowing of daughter cell separation upon the
last divisions before stationary phase. Like previously, we
verified the authenticity of the "bibudded" phenotype by
mixing two populations of cells, each expressing one dif-
ferent GFP variant. When this mixed population reached
the diauxic shift, we counted the number of cells with two
apparent daughters and examined them by fluorescence
microscopy. Similar to our results for MPA-treated cells,
only 0.9% ± 0.7% of the apparent "bibudded" cells were
bicolor (more than 200 "bibudded" cells were counted for
each experiment). Thus, we concluded that those cells
were indeed cells with two daughters. This was further
supported by observation of those cells by electron micro-
scopy (not shown). We obtained similar results with both
the BY4742 and the FL100 genetic background (data not
shown) demonstrating that the appearance of cells with
two daughters is not specific to the BY4742 background.
In conclusion, when a yeast culture approaches stationary
phase, a significant proportion of cells behaves like cells
in which the intracellular guanylic nucleotide pools have
been depleted and give rise to cells with two unseparated
daughters.
Discussion
Guanylic nucleotides are not only "building blocks" for
nucleic acids but are also crucial for the regulation of
many cellular processes such as G-proteins based signal-
ing pathways. Therefore, cells must maintain their
concentrations at a critical level. However, the molecular
relationships between intracellular guanylic nucleotide
levels and cell proliferation crucial events remain poorly
understood.
Here, we have demonstrated that MPA treatment does not
cause a firm cell cycle arrest in yeast. Treated cells continue
to proliferate, although at a reduced rate (this study and
[18]). Further, we have shown that conditional mutants
unable to synthesize guanylic nucleotides do not arrest in
a particular stage of the cell cycle. Therefore, our results
establish that there is no guanylic nucleotide checkpoint
is S. cerevisiae. By contrast, in mammalian cells, it was
previously shown that MPA treatment cause an arrest of
cellular proliferation but no guanylic nucleotide specific
checkpoint has clearly been identified. Several reports
have described that MPA treatment affects mammalian
cells ability to commit into division by blocking the tran-
sition from G0 to the S phase of the cell cycle [13,17,22].
However, if MPA is added when cells have already entered
the S phase, the cell cycle arrest occurs in G2/M [22].
Besides, the MPA-induced arrest is not fully reversed by
the replenishment of guanylic nucleotide pools
[13,17,22]. Here, we have shown that even if MPA treat-
ment slows all stages of the yeast cell cycle progression,
the most affected step is the mother-daughter cell wall
separation, giving rise to "bibudded" cells. This result sup-
ports our previous observation that MPA treatment leads
to the appearance of many cells with 3N DNA content
[18]. Importantly, MPA treatment has the same effects on
both non-synchronized and synchronized cells treated
with the drug upon release from G1 (Fig. 2) or upon
release from G2/M after nocodazole synchronization (I.
S., B. D.-F. unpublished results). Therefore, unlike in
mammals, in yeast, MPA treatment causes the same effects
whatever the cell cycle stage of the cells at the time of drug
addition. Further, our analysis of mutants demonstrates
that the mother-daughter separation defect results solely
from guanylic nucleotide pools depletion and is inde-
pendent of potential MPA secondary targets.
In yeast, the fact that a guanylic nucleotides starvation
causes a mother-daughter separation defect was unex-
pected. Indeed, one could have intuitively supposed that
this depletion would rather provoke a drastic defect dur-
ing DNA replication upon S phase or disturb cell cycle
steps for which GTPase driven molecular processes are
essential. In fact, upon MPA treatment, cells can still build
a daughter cell and cell polarity was found even less
affected in this study than in our earlier work [18]. Daugh-
ter cell appears to grow normally, mitosis proceeds unper-
turbed, and mother-daughter closure is properly achieved.
Thus, guanylic nucleotides starvation does not critically
affect the functions of key GTP binding proteins, such as
Cdc42p, Tem1p, tubulin and septins. In this study we
observed that in the "bibudded" cells, placement of the
second daughter cell properly follows the axial budding
pattern of haploid cells, suggesting that the bud-site selec-
tion machinery is properly located. In contrast, prolonged
MPA treatment (48 hours) leads to a random budding
pattern [18]. Thus, long-term guanylic nucleotides starva-
tion may have more drastic effects. Most importantly, our
experiments show that complete mother-daughter separa-
tion is not required for the mother cell to pass through
START and to generate a second daughter cell (Fig. 2E).
Therefore, our data confirm that no additional checkpointBMC Cell Biology 2005, 6:24 http://www.biomedcentral.com/1471-2121/6/24
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Effects of MPA on the yeast cell wall Figure 6
Effects of MPA on the yeast cell wall. A. Percentage of unbudded (shadow bars), single budded (white bars) and of cells 
with two buds (grey bars) after 4 hours treatment with 100 µg/mL MPA followed by a mild digestion of the cell wall with zymo-
lyase. More than 200 cells were counted for each condition. B. Electron microscopy pictures of cells with two buds obtained 
after 4 hours treatment with 100 µg/mL MPA. Untreated control cells are shown on the right panel each steps of the septum 
formation are illustrated (from top to bottom).
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blocks the cell cycle progression when anaphase is prop-
erly achieved.
What molecular targets trigger the mother-daughter sepa-
ration defect upon guanylic nucleotide starvation? Obser-
vation of "bibudded" cells by electron microscopy
revealed no obvious defect in the overall septum architec-
ture of abnormally unseparated daughter cell. Neverthe-
less, MPA treatment increases cells sensitivity to SDS [19],
zymolyase or sonication (I. S., B. D.-F. unpublished
results), strongly suggesting cell wall defects. In fact, pre-
vious works have illustrated links between guanylic nucle-
otides metabolism and cell wall integrity, particularly
through the synthesis of mannoproteins, essential com-
ponents of the fungal cell wall. GDP-mannose is the com-
mon substrate for mannosyltransferases, enzymes
catalyzing the addition of mannose residues on
mannoproteins core oligosaccharides. In budding yeast,
the GDP-mannose pyrophosphorylase Psa1p is an essen-
tial enzyme that synthesizes GDP-mannose, using GTP as
a substrate. It was previously shown that MPA treatment
affects Psa1p expression [18] and that Psa1p depletion
leads to cell separation failure [23]. Further, Shimma et al
have demonstrated that the major defect of a guk1 condi-
tional mutant strain, that is impaired for GDP biosynthe-
sis (Fig. 1), was a decrease in GDP-mannose level (to
about 25% of the wild type levels) that leads to mannose
outer chain elongation defects [24]. Accordingly, we have
observed cell separation defect in guk1 cells (I. S., B. D.-F.,
unpublished results). In addition, yeast lacking manno-
syltransferase encoding genes, such as OCH1, MNN10 or
ANP1 display both hypersensitivity to MPA [19] and a cell
separation defect similar to the one observed for guanylic
nucleotide starved cells [25-27]. Therefore, one major
consequence of guanylic nucleotide starvation could be a
significant decrease in the GDP-mannose pool that in turn
leads to a mother-daughter separation defect.
The most intriguing aspect of the regulation of intracellu-
lar guanylic nucleotide pools is the correlation between
Number of cells with two daughters as a function of the age of the culture Figure 7
Number of cells with two daughters as a function of the age of the culture. WT cells were grown in SC medium and 
the percentage of cells with two daughters among budding cells as a function of time was counted (black circles). For each time 
point, more than 300 cells were counted. OD600 nm is indicated as a black bold line.
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the IMPDH activity and cellular proliferation in mamma-
lians models. Interestingly, the transcription of the IMD2
gene is actively shut off via regulatory sequences when
yeast cells enter stationary phase upon nutrients
limitation [2]. Transcriptome analyses have demonstrated
that  AAH1,  HPT1  and  GUA1  are among the most
promptly down regulated genes when nutrients become
limiting. Thus, it appears that an entire process is devoted
to rapidly decrease the intracellular guanylic nucleotide
pools when cells enter stationary phase. Here, we have
demonstrated that the typical "bibudded" phenotype
obtained during guanylic nucleotide starvation also
occurs in untreated wild type cells achieving their last divi-
sions upon nutrients limitation. Thus, an identical mor-
phology is observed for both guanylic nucleotide
starvation and entry into quiescence.
Finally, the GTP/GDP ratio is very sensitive to growth con-
ditions, rapidly decreasing during the diauxic shift and
drastically dropping upon nutrients starvation. Further,
this ratio may regulate RAS GTPases activity by
influencing its guanylic nucleotide loading equilibrium
[11]. RAS and TOR pathways are key regulators that coor-
dinate yeast proliferation with nutrients availability.
Recent work has suggested that the TOR protein acts as
ATP sensor in mammals [28]. Thus it is appealing to spec-
ulate that in parallel to the TOR pathway, intracellular
guanylic nucleotides levels are part of a signal that regu-
late cell proliferation via the modulation of RAS GTPases
activity.
Conclusion
Using either mycophenolic acid, a molecule that specifi-
cally inhibits the first committed step in de novo GMP bio-
synthesis or mutations in the guanylic nucleotide
biosynthesis pathway, we have demonstrated that intrac-
ellular guanylic nucleotides limitation causes a mother-
daughter cell wall separation defect in budding yeast. This
defect leads to the emergence of cells with two unsepa-
rated daughters. These "bibudded" cells are also found in
a population of cells entering quiescence upon nutrient
limitation. These observations further suggest that guan-
ylic nucleotide intracellular pools might contribute to a
signal that regulates cell proliferation, particularly upon
nutrients limitation and entry into stationary phase.
Methods
Strains, media and reagents
Yeast strains used were purchased from Euroscarf (Frank-
furt, Germany) and are derivatives of BY4741 or BY4742
[29]. SD and SD casa media were described previously [2]
and were supplemented when required with tryptophan
(0.2 mM), uracil (1.8 mM), guanine (0.3 mM), adenine
(0.3 mM), hypoxanthine (0.3 mM). Cycloheximide was
purchased from Sigma and used at 50 µg/mL. Mycophe-
nolic acid (MPA) was purchased from Amresco, (Ohio,
USA) and was used at 100 µg/mL.
Plasmids
pB1594 integrates three tandem copies of GFP at the 3'
end of the LTE1 coding region (Lte1p-3xGFP) and is a
kind gift of D. Pellman [30]. pB1598 integrates three tan-
dem copies of GFP at the 3' end of the TEM1  coding
region (Tem1p-3xGFP) and is a kind gift of D. Pellman.
pYB407 (GFP-Cdc12p – LEU2 – CEN) is a kind gift of Y.
Barral [31]. pVTYS65T (URA3, 2µ) allows the expression
of the GFP variant containing the S65T mutant (fluores-
cence maxima: Ex: 488 nm, Em: 511 nm) and has been
previously described [32]. pVTYBFP2 allows the expres-
sion of a GFP variant containing mutations F64L, S65T,
Y66H et Y145F which coding sequence has been opti-
mized for expression in yeast (fluorescence maxima: Ex
380 nm, Em 440 nm see [33]). Details of the mutagenesis
and constructions are available upon request.
Cell Biology techniques and Fluorescence Microscopy
Cells were synchronized by addition of alpha-factor at the
final concentration of 10 µg/mL directly into the growth
medium. After 3 hours of incubation at 30°C with agita-
tion, more than 99% of the cells were unbudded. Cells
were washed twice and released into fresh SD medium
containing or not MPA. Propidium iodide (Sigma) stain-
ing was performed as described in [34] except that cells
were fixed with ethanol 70%. Alexa-568-Phalloidin
(Molecular Probes, Eugene, OR) was used to stain fila-
mentous actin as described previously [35]. Zymolyase
20T (ICN Biomedicals, Costa Mesa, CA) was used at 0.2
mg/mL on formaldehyde fixed cells resuspended in PBS.
Images were acquired with a Marianas system and ana-
lyzed with the Slidebook software (Intelligent Imaging
Innovations, Inc. Denver, CO) except for GFP-Cdc12p
expressing cells that were imaged with a previously
described imaging system [32].
Electron Microscopy
Cells were grown in SD medium to OD600 nm = 0.2 at
30°C. MPA was added to the final concentration of 100
µg/mL and cells were grown for four more hours. Cells
were then fixed with glutaraldehyde and osmic acid, and
then stained by the method of Thiéry as previously
described [36].
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